Kura Oncology (KURA) Shares Outstanding (2010 - 2026)

Kura Oncology (KURA) has 17 years of Shares Outstanding data on file, last reported at $88.8 million in Q1 2026.

• Quarterly Shares Outstanding rose 9.89% year-over-year to $88.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $88.8 million (up 9.89% YoY) and the FY2025 annual result came in at $87.9 million, up 12.3% from the prior year.
• Shares Outstanding improved to $88.8 million in Q1 2026 per KURA's latest filing, from $87.9 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $88.8 million in Q1 2026 and bottomed at $66.6 million in Q1 2022.
• The 5-year median for Shares Outstanding is $76.2 million (2024), against an average of $76.5 million.
• The widest annual swing landed in 2022, when Shares Outstanding advanced 0.56%; it then gained 13.58% in 2025.
• Tracing KURA's Shares Outstanding over 5 years: stood at $68.3 million in 2022, then rose by 8.84% to $74.4 million in 2023, then gained by 5.22% to $78.2 million in 2024, then grew by 12.3% to $87.9 million in 2025, then advanced by 1.03% to $88.8 million in 2026.
• Per Business Quant, the three latest KURA Shares Outstanding figures stand at $88.8 million (Q1 2026), $87.9 million (Q4 2025), and $87.0 million (Q3 2025).

Peer Comparison